NVO vs C Comparison

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Citigroup is a global financial powerhouse that orchestrates the movement of over $6 trillion in daily transaction volume, serving as the essential connective tissue for the world's most complex multinational corporations. The firm services 90% of the Fortune 500 through a proprietary network that includes direct membership to over 270 cash-clearing centers and a footprint that spans 94 countries. After a checkered history operating as an overly complex, disjointed firm, it has taken steps to streamline operations, resulting in organization across five segments: services, markets, banking, wealth, and US personal banking.